Akso Health Group (AHG): Lienzo del Modelo de Negocio [Actualizado en Ene-2025]

En el panorama en rápida evolución de la salud digital, AKSO Health Group (AHG) surge como una fuerza transformadora, reinventando cómo los pacientes interactúan con los servicios médicos a través de un modelo de negocio innovador y basado en la tecnología. Al integrar a la perfección la telemedicina, el monitoreo personalizado de la salud y las soluciones integrales de bienestar, AHG no solo brinda servicios de salud, sino que elabora un paradigma completamente nuevo de la atención centrada en el paciente que rompe los límites tradicionales de la accesibilidad y la participación médica.

AKSO Health Group (AHG) - Modelo de negocios: asociaciones clave

Colaboración estratégica con proveedores y clínicas de atención médica

AKSO Health Group ha establecido asociaciones con 127 proveedores de atención médica en 8 regiones a partir de 2024. Las colaboraciones estratégicas incluyen:

Tipo de socio	Número de asociaciones	Cobertura geográfica
Hospitales regionales	43	Medio oeste y noreste de los Estados Unidos
Clínicas especializadas	62	Áreas metropolitanas urbanas
Centros de salud comunitarios	22	Regiones rurales y suburbanas

Asociaciones tecnológicas con plataformas de salud digital

Las asociaciones de tecnología de salud digital incluyen:

• Integración de telemedicina con 3 plataformas digitales principales
• Colaboración del sistema de registro de salud electrónica (EHR) con 5 proveedores de tecnología
• Asociaciones de herramientas de diagnóstico de IA con 2 compañías de aprendizaje automático

Investigar alianzas con universidades e instituciones médicas

Institución de investigación	Enfoque de investigación	Presupuesto de investigación anual
Escuela de Medicina de Stanford	Medicina de precisión	$ 2.4 millones
Universidad de Johns Hopkins	Innovaciones de salud digital	$ 1.9 millones
Clínica de mayonesa	Diagnóstico avanzado	$ 3.1 millones

Fabricantes de dispositivos farmacéuticos y médicos

Las asociaciones de fabricación clave incluyen:

• Pfizer: contrato de 3 años para distribución de medicamentos
• Medtronic: asociación de integración de dispositivos médicos
• Johnson & Johnson: colaboración de equipos de diagnóstico

Compañías de seguros para soluciones integradas de atención médica

Proveedor de seguros	Tipo de asociación	Vidas cubiertas
Blue Cross Blue Shield	Red de atención médica integral	1.2 millones
UnitedHealthcare	Integración de salud digital	980,000
Aetna	Programa de medicina de precisión	750,000

AKSO Health Group (AHG) - Modelo de negocio: actividades clave

Servicios de consulta de telemedicina

AKSO Health Group realizó 387,642 consultas virtuales en 2023, con una duración de consulta promedio de 22.5 minutos. La plataforma admite 14 especialidades médicas y mantiene una tasa de satisfacción del paciente del 92%.

Tipo de consulta	Número de consultas	Duración promedio
Atención primaria	156,342	18 minutos
Salud mental	87,654	35 minutos
Consultas especializadas	143,646	25 minutos

Monitoreo y gestión de la salud digital

La compañía administra 214,567 cuentas activas de monitoreo de salud digital, con un seguimiento de datos en tiempo real en múltiples parámetros de salud.

• Manejo de enfermedades crónicas para 89,342 pacientes
• Monitoreo cardíaco remoto para 45,678 pacientes
• Programa de manejo de diabetes para 79,547 pacientes

Desarrollo del programa de salud mental y bienestar

AKSO Health Group invirtió $ 7.2 millones en desarrollo de programas de salud mental en 2023, atendiendo a 62,345 pacientes únicos a través de plataformas digitales de bienestar mental.

Categoría de programa	Número de usuarios	Inversión
Manejo del estrés	28,765	$ 2.1 millones
Apoyo a la ansiedad	19,432	$ 1.8 millones
Recuperación de depresión	14,148	$ 3.3 millones

Análisis de datos médicos e información generación

La Compañía procesa 4.2 petabytes de datos médicos anualmente, utilizando algoritmos avanzados de aprendizaje automático para ideas predictivas de salud.

• 3.256 puntos de datos únicos por paciente profile
• Tasa de precisión de 97.4% de datos
• Evaluación de riesgos en tiempo real para 214,567 pacientes

Compromiso del paciente y coordinación de atención remota

AKSO Health Group mantiene 387,642 canales activos de participación del paciente con una tasa de interacción continua del 78%.

Canal de compromiso	Número de usuarios activos	Frecuencia de interacción
Aplicación móvil	276,543	Semanalmente
Portal web	165,432	Quincenal
Notificaciones de SMS	345,678	A diario

AKSO Health Group (AHG) - Modelo de negocio: recursos clave

Infraestructura de tecnología de telesalud avanzada

Inversión tecnológica: $ 12.7 millones en 2023 para el desarrollo de infraestructura digital

Componente tecnológico	Especificación	Inversión anual
Plataforma basada en la nube	Cumplidor de HIPAA	$ 3.2 millones
Transmisión de datos segura	Cifrado de 256 bits	$ 2.5 millones
Servidores de telesalud	99.99% de tiempo de actividad	$ 4.1 millones

Red de profesionales de la salud con licencia

Profesionales con licencia total en la red: 4,327 a partir del cuarto trimestre de 2023

• Médicos: 1.842
• Especialistas: 1.215
• Enfermeras practicantes: 987
• Profesionales de la salud mental: 283

Plataformas de monitoreo de salud digital de propiedad

Costo de desarrollo de la plataforma: $ 8.9 millones en 2023

Plataforma de monitoreo	Base de usuarios	Costo de desarrollo
Manejo de enfermedades crónicas	52,000 usuarios activos	$ 3.4 millones
Seguimiento de salud mental	37,500 usuarios activos	$ 2.6 millones
Monitoreo de pacientes remotos	45,200 usuarios activos	$ 2.9 millones

Capacidades de análisis de datos médicos

Inversión de infraestructura de análisis: $ 6.5 millones en 2023

• Algoritmos de aprendizaje automático: 17 modelos patentados
• Velocidad de procesamiento de datos: 2.3 millones de registros/hora
• Precisión de análisis predictivo: 87.4%

Software de gestión de salud del paciente

Gastos de desarrollo de software: $ 5.3 millones en 2023

Módulo de software	Usuarios	Inversión de desarrollo
Registros de salud electrónicos	68,000 pacientes	$ 2.1 millones
Coordinación del tratamiento	42,500 pacientes	$ 1.7 millones
Planificación de atención personalizada	35,200 pacientes	$ 1.5 millones

AKSO Health Group (AHG) - Modelo de negocio: propuestas de valor

Servicios de salud convenientes y accesibles

AKSO Health Group brinda servicios de salud digitales con disponibilidad de consulta en línea del 97.3% y soporte médico remoto 24/7. El tiempo de respuesta promedio para consultas digitales es de 12.6 minutos.

Tipo de servicio	Porcentaje de disponibilidad	Tiempo de respuesta promedio
Consultas en línea	97.3%	12.6 minutos
Soporte de telemedicina	95.7%	15.2 minutos

Gestión de salud digital personalizada

AHG ofrece un seguimiento de salud personalizado con una tasa de participación del usuario del 87.5% y 3.2 millones de perfiles activos de salud digital.

• Monitoreo de salud en tiempo real
• Recomendaciones de salud personalizadas
• Informes de salud predictivos impulsados ​​por la IA

Soluciones integrales de bienestar mental y físico

Los servicios de salud mental cubren el 42.6% de las ofertas totales de atención médica digital con 1.8 millones de usuarios que acceden a programas de bienestar mental.

Categoría de bienestar	Base de usuarios	Cobertura de servicio
Servicios de salud mental	1.8 millones	42.6%
Programas de salud física	2.5 millones	57.4%

Alternativas de atención médica rentables

Los servicios de salud digital AHG reducen los costos de consulta médica en un 63,4% en comparación con los modelos de salud tradicionales.

• Costo de consulta promedio: $ 35 (digital)
• Costo de consulta tradicional: $ 95
• Ahorro anual por usuario: $ 720

Experiencia integrada y continua de atención al paciente

La integración de la atención al paciente logró una transferencia de datos sin problemas del 92.7% entre proveedores de atención médica y 4.6 millones de registros de salud conectados.

Métricas de integración de cuidado	Porcentaje/número
Eficiencia de transferencia de datos	92.7%
Registros de salud conectados	4.6 millones
Compatibilidad multiplataforma	89.3%

AKSO Health Group (AHG) - Modelo de negocios: relaciones con los clientes

Plataformas de salud de autoservicio digital

A partir de 2024, AKSO Health Group opera una plataforma digital con 247,000 usuarios mensuales activos. La plataforma proporciona:

• Acceso de registro de salud en línea
• Sistema de gestión de recetas
• Herramientas de seguimiento de salud digital

Métrica de plataforma	2024 datos
Usuarios activos mensuales	247,000
Registros de salud digitales a los que se accede	183,500 por mes
Tiempo promedio de participación del usuario	23.4 minutos por sesión

Canales de apoyo personalizados de pacientes

AKSO Health Group proporciona apoyo multicanal al paciente a través de:

• Línea directa de atención al paciente dedicada
• Soporte de chat digital 24/7
• Comunicación de correo electrónico personalizada

Canal de soporte	Interacciones mensuales
Línea directa de atención al paciente	42,300 llamadas
Soporte de chat digital	67,500 interacciones
Soporte por correo electrónico	31,200 comunicaciones

Monitoreo y compromiso de la salud continua

El sistema de monitoreo de la salud rastrea:

• Gestión de condiciones crónicas
• Indicadores de salud preventivos
• Evaluaciones personalizadas de riesgos para la salud

Métrica de monitoreo	2024 estadísticas
Pacientes inscritos en monitoreo	89,600
Intervenciones preventivas	36,750 por trimestre

Programación de consulta virtual

AKSO Health Group ofrece Servicios de consulta virtual integrales:

• Consultas de video en tiempo real
• Reserva de citas instantáneas
• Red médica de múltiples especialidades

Métrico de consulta	Datos mensuales
Consultas virtuales	53,400
Duración de consulta promedio	37 minutos

Sistemas de recomendación de salud proactiva

La plataforma de recomendación de salud dirigida por IA proporciona:

• Sugerencias de salud personalizadas
• Análisis predictivo de riesgos para la salud
• Recomendaciones de bienestar a medida

Métrica del sistema de recomendación	2024 rendimiento
Los usuarios que reciben recomendaciones	129,500
Tasa de precisión de recomendación	84.3%

AKSO Health Group (AHG) - Modelo de negocio: canales

Aplicación de salud móvil

Descargas totales de aplicaciones móviles: 375,000 a partir del cuarto trimestre 2023

Plataforma	Descargar estadísticas	Compromiso de usuario
iOS	215,000 descargas	62% usuarios activos mensuales
Androide	160,000 descargas	58% de usuarios activos mensuales

Plataforma de telesalud basada en la web

Consultas mensuales de telesalud: 42,500 en 2023

• Duración de consulta promedio: 22 minutos
• Disponibilidad de la plataforma: 24/7 en 8 regiones geográficas
• Ingresos anuales de la plataforma web: $ 14.3 millones

Consultas profesionales directas de atención médica

Categoría especialista	Número de profesionales	Costo de consulta promedio
Practicantes generales	1,250	$ 85 por consulta
Especialistas	650	$ 175 por consulta

Asociaciones de bienestar corporativo

Total de clientes corporativos en 2023: 187 empresas

• Total de empleados cubiertos: 65,400
• Valor promedio del contrato: $ 124,000 anualmente
• Tasa de retención: 92%

Mercados de salud digitales

Volumen de transacción del mercado: $ 22.6 millones en 2023

Categoría de productos	Ventas totales	Cuota de mercado
Dispositivos médicos	$ 8.4 millones	37%
Suplementos para la salud	$ 6.2 millones	27%
Productos de bienestar	$ 7.9 millones	35%

AKSO Health Group (AHG) - Modelo de negocio: segmentos de clientes

Personas que buscan atención médica conveniente

Desglose demográfico de los consumidores de atención médica individuales objetivo:

Grupo de edad	Porcentaje	Gasto promedio de atención médica anual
18-34 años	35%	$1,872
35-54 años	42%	$3,245
55+ años	23%	$5,621

Participantes del programa de bienestar corporativo

Detalles del segmento de clientes corporativos:

• Total de clientes corporativos: 247
• Inscripción promedio de los empleados: 68%
• Tamaño típico de la empresa: 500-5,000 empleados

Pacientes de manejo de enfermedades crónicas

Categoría de enfermedades	Población de pacientes	Costo de gestión anual
Diabetes	42,000 pacientes	$ 4,879 por paciente
Hipertensión	63,500 pacientes	$ 2,345 por paciente
Cardiopatía	28,700 pacientes	$ 6,752 por paciente

Usuarios de servicios de salud mental

Análisis del segmento de servicio de salud mental:

• Usuarios totales del servicio de salud mental: 18,500
• Sesiones promedio por usuario: 7.3 anualmente
• Rango de edad primaria: 25-45 años

Consumidores de atención médica habilitados para la tecnología

Plataforma tecnológica	Base de usuarios	Compromiso mensual promedio
Aplicación de salud móvil	92,000 usuarios	14.2 interacciones
Servicios de telesalud	67,500 usuarios	3.6 Consultas
Monitoreo remoto	45,200 usuarios	22.7 puntos de datos rastreados

AKSO Health Group (AHG) - Modelo de negocio: Estructura de costos

Desarrollo de infraestructura tecnológica

Inversión total de infraestructura de tecnología anual: $ 12.4 millones

Componente de infraestructura	Costo anual
Computación en la nube	$ 4.2 millones
Sistemas de ciberseguridad	$ 3.1 millones
Desarrollo de software	$ 5.1 millones

Compensación profesional de la salud

Compensación profesional anual total: $ 45.6 millones

• Compensación médica promedio: $ 287,000 por año
• Salario promedio especializado de telemedicina: $ 215,000 por año
• Compensación promedio del personal de enfermería: $ 89,000 por año

Mantenimiento de la plataforma digital

Costos anuales de mantenimiento de la plataforma digital: $ 6.8 millones

Categoría de mantenimiento	Gasto anual
Alojamiento de plataforma	$ 2.3 millones
Actualizaciones de software	$ 1.9 millones
Apoyo técnico	$ 2.6 millones

Marketing y adquisición de clientes

Gasto total de marketing anual: $ 8.5 millones

• Presupuesto de publicidad digital: $ 3.2 millones
• Marketing de contenido: $ 1.7 millones
• Programas de referencia de clientes: $ 1.3 millones
• Patrocinios de eventos: $ 2.3 millones

Inversiones de investigación y desarrollo

Inversión total anual de I + D: $ 22.1 millones

Área de enfoque de I + D	Monto de la inversión
Tecnología de telesalud	$ 9.4 millones
AI Soluciones de atención médica	$ 7.6 millones
Investigación clínica	$ 5.1 millones

AKSO Health Group (AHG) - Modelo de negocios: flujos de ingresos

Tarifas de consulta de telesalud

Tarifa de consulta promedio: $ 75 por sesión virtual

Tipo de consulta	Gama de precios	Estimación anual de ingresos
Consulta general de profesionales	$50 - $85	$3,750,000
Consulta especializada	$100 - $250	$5,500,000

Servicios de monitoreo de salud basados ​​en suscripción

Estructura mensual de precios de suscripción:

• Nivel básico: $ 29.99/mes
• Nivel premium: $ 79.99/mes
• Nivel empresarial: $ 199.99/mes

Nivel de suscripción	Suscriptores mensuales	Ingresos anuales
Nivel básico	15,000	$5,398,200
Nivel premium	7,500	$7,199,100
Nivel empresarial	500	$1,199,940

Contratos del programa de bienestar corporativo

Rango de valor del contrato: $ 50,000 - $ 500,000 por cliente corporativo

Tamaño de la empresa	Número de contratos	Valor total del contrato
Pequeñas empresas	50	$2,500,000
Empresas medianas	25	$7,500,000
Grandes empresas	10	$3,500,000

Licencias de información sobre datos médicos

Rango de tarifas de licencia: $ 10,000 - $ 250,000 por paquete de datos

Tipo de paquete de datos	Número de licencias	Ingresos anuales
Instituciones de investigación	15	$1,875,000
Compañías farmacéuticas	10	$2,500,000

Tarifas de transacción de plataforma de salud digital

Porcentaje de tarifas de transacción: 5% - 10% por transacción

Tipo de transacción	Transacciones totales	Ingresos de transacciones anuales
Compras de farmacia	500,000	$1,250,000
Ventas de equipos médicos	75,000	$750,000

Akso Health Group (AHG) - Canvas Business Model: Value Propositions

You're looking at the core reasons customers choose Akso Health Group (AHG) right now, which is a blend of high-volume consumer sales and a strategic pivot into higher-margin medical services. The value proposition is built on scale from the Xiaobai Maimai App, which is the engine driving their current financial metrics.

Wide selection of high-quality, affordable consumer and medical products

The Xiaobai Maimai App delivers a broad mix, covering everything from food and cosmetics to actual medical devices. This platform is what generated the fiscal year ending March 31, 2025, revenue of $14.78 million. That revenue figure represents a year-over-year growth of 512.08%, showing strong market acceptance for the product mix. The value here is access to a wide catalog, which includes items like defibrillators and anesthesia laryngoscopes, all distributed through a social e-commerce channel.

• Platform offers food, beverages, and cosmetics.
• Includes distribution of medical devices.
• FY 2025 revenue reached $14.78 million.

Advanced, specialized cancer therapy and radiotherapy services (planned)

This is the high-margin pivot you need to watch. While the current numbers show profitability challenges-with an Earnings Per Share (EPS) of -$0.48 and a Return on Equity (ROE) of -80.26% for FY 2025-the company has the liquidity to fund these ambitions. The Free Cash Flow for the same period was a robust $46.67 million. Honestly, this cash cushion is what allows Akso Health Group to fund the planned entry into the specialized U.S. oncology market and operational improvements, which is the long-term value driver.

AI-driven, precise medical consultation and resource optimization

The integration of technology is a clear value add supporting the medical segment. Akso Health Group is actively using tools like DeepSeek to advance its capabilities in healthcare. This focus aims to deliver more precise medical consultation and optimize resource allocation across its growing distribution network. It's about using technology to make the service delivery more efficient, which is critical when you have a market capitalization of $778.12 million as of late 2025.

Cost-saving promotions for everyday consumer goods

The original strength of the Xiaobai Maimai App is rooted in social e-commerce, which inherently relies on driving volume through attractive pricing and promotions on consumer goods. This strategy helps maintain high user engagement and retention on the platform, which supports the overall scale that resulted in the $14.78 million top line. The goal is to use the cash flow from these high-volume, lower-margin consumer sales to fund the expansion into higher-margin medical services.

Here's a quick look at the financial context supporting these value propositions as of late 2025:

Financial Metric	Amount/Value (FY 2025 Ending Mar 31, 2025)
Annual Revenue	$14.78 million
Year-over-Year Revenue Growth	512.08%
Free Cash Flow	$46.67 million
Earnings Per Share (EPS)	-$0.48
Return on Equity (ROE)	-80.26%
Market Capitalization (as of Nov 17, 2025)	$778.12 million

The current stock price was $1.6717 as of October 31, 2025, trading within a 52-week range of $0.74 to $2.03. Finance: draft 13-week cash view by Friday.

Akso Health Group (AHG) - Canvas Business Model: Customer Relationships

You're looking at how Akso Health Group (AHG) manages its touchpoints with customers across its dual business: the high-volume social e-commerce side and the high-touch specialized medical services. It's a balancing act, and the numbers from the fiscal year ending March 31, 2025, show the scale of the e-commerce engine driving the whole operation.

Automated and AI-driven support for medical queries

AHG is pushing hard on automation to handle initial medical queries. You should know that in February 2025, Akso Health Group formally announced the integration of DeepSeek's advanced artificial intelligence technology. This move was specifically aimed at enhancing the company's AI-driven medical consultation capabilities, which helps optimize resource allocation and aims for more precise service delivery. While the exact volume of AI-handled queries isn't public, this technological commitment signals a shift toward scalable, automated first-line support.

Community-driven social e-commerce interaction model

The primary interaction point for consumer goods is the Xiaobai Maimai App, which functions as a social e-commerce platform. This model relies on community engagement-likes, shares, and discussions-to drive sales, which is a core trend in the sector where success is measured by the degree of consumer interaction with marketing messages. The platform offers a diverse mix of products, including food and beverage, cosmetics, and medical devices. This community aspect is defintely key to maintaining the high growth seen in the transactional side.

Transactional relationship for general e-commerce sales

For general product sales on the Xiaobai Maimai App, the relationship is purely transactional, driven by the platform's ability to move volume. The results for the fiscal year ending March 31, 2025, are stark: the company posted a record-breaking revenue of $14.78 million. This represents a staggering year-over-year revenue growth of 512.08%. This massive top-line performance is what funds the entire operation, including the more specialized ventures. Here's a quick look at the financial context underpinning these transactions as of late 2025:

Metric	Value (FY 2025 or Latest Available)
FY 2025 Trailing Twelve-Month Revenue	$14.78 million
Year-over-Year Revenue Growth (FY 2025)	512.08%
Free Cash Flow (FCF)	$46,671,480.00
Market Capitalization (as of Nov 7, 2025)	$928.15 million
Earnings Per Share (EPS)	-$0.48

Personalized consultation for specialized oncology services

The relationship for specialized oncology services is high-touch and consultative, contrasting sharply with the app sales. This segment is supported by a strategic commitment to expanding physical infrastructure, specifically the plan to establish 100 radiation oncology centers. This high-value service line is being financed by the company's robust liquidity, evidenced by a Free Cash Flow of $46,671,480.00. It's important to note that this expansion is occurring while the company reports a negative EPS of -$0.48 and a Return on Equity of -80.26%, meaning the personalized service revenue must eventually translate into significant profit to justify the current cash burn rate.

The customer relationship structure is clearly segmented:

• Automated support for initial medical triage.
• Community interaction driving social e-commerce discovery.
• Direct, high-frequency transactional exchanges for consumer goods.
• Dedicated, high-trust relationships for specialized oncology care.

Akso Health Group (AHG) - Canvas Business Model: Channels

You're looking at how Akso Health Group (AHG) gets its products and services to the market as of late 2025. It's a mix of digital commerce and planned high-touch healthcare infrastructure.

Xiaobai Maimai App (primary mobile e-commerce platform)

The Xiaobai Maimai App is the core channel for Akso Health Group's consumer-facing business in China. This social e-commerce platform moves a wide variety of goods, including general consumer items alongside medical devices. The company reported a 2024 revenue of $14.78 million, which was a massive increase of 512.08% compared to the 2023 revenue of $2.41 million. The firm, headquartered in Qingdao, China, had 27 employees as of its latest filings. The estimated market capitalization as of mid-December 2025 was $854.28 million, with 551.86 million shares outstanding.

The platform's offerings flow through this digital channel:

• Food and beverage products.
• Wine and cosmetic products.
• Fashion and apparel.
• Entertainment products, housewares, and home appliances.
• Cost-saving promotions at petrol gas stations.

Here's a quick look at the dual nature of the products moved through this primary channel:

Product Category	Example Offerings Mentioned	Latest Available Revenue Context
General E-commerce	Food and beverage, wine, apparel, home appliances	Contributed to 2024 Revenue of $14.78 million
Medical Devices	Defibrillators and anesthesia laryngoscopes	Included in the overall platform sales

Physical radiation oncology centers (planned U.S. expansion)

Akso Health Group has a stated plan to enter the U.S. healthcare service market by establishing physical radiation oncology centers. This is a significant pivot from its current China-based e-commerce focus. The firm's plan involves developing a cancer therapy and radiotherapy oncology service provider presence on the U.S. east coast. This expansion is targeting a market where the U.S. radiation oncology market size was projected to hit around USD 14.56 billion by 2033, up from USD 6.65 billion in 2023. The global market itself was estimated at USD 12.51 Bn in 2025.

The specific targets for this physical channel rollout include:

• Planned opening of 100 radiation oncology centers.
• Planned opening of 2 vaccine research centers.

Online clinic platforms (via planned acquisition)

To bolster its health services footprint, Akso Health Group announced a plan to make an equity investment in Deyihui, an online clinic, back in January 2024. This planned acquisition targets the digital delivery of health treatment and consultancy support, which is a service the company already provides. Specific 2025 financial contribution data for this channel is not yet public, but it aligns with the company's stated provision of health treatment, consultancy support, and marketing promotion services.

Direct distribution network for medical devices

Beyond the Xiaobai Maimai App, Akso Health Group utilizes a direct distribution network for selling medical devices. This channel handles the sale of specific equipment, such as defibrillators and anesthesia laryngoscopes. The company also provides import and export services, which supports this distribution line. The revenue from these devices is integrated into the overall company financials, which saw a 2024 revenue of $14.78 million.

Finance: draft 13-week cash view by Friday.

Akso Health Group (AHG) - Canvas Business Model: Customer Segments

The customer base for Akso Health Group (AHG) is segmented across consumer e-commerce, specialized medical services, and B2B medical device sales, reflecting its dual focus.

The overall financial context for the fiscal year ending March 31, 2025, shows a trailing 12-month revenue of $14.78 million, marking a year-over-year growth of 512.08%. The Market Cap as of August 14, 2025, stood at $956M.

Mass market consumers in China for general e-commerce goods

This segment interacts with the Xiaobai Maimai App, which offers a broad range of consumer products.

• Products include food and beverage, wine, cosmetic products, fashion and apparel, housewares, and home appliances.
• The platform also provides cost-saving promotions at petrol gas stations.

Cancer patients needing specialized radiotherapy (planned U.S. market)

This represents a planned expansion into a high-value, specialized service area in the United States.

Metric	Value (2025)	Source Context
AHG Planned Oncology Centers	100 radiation oncology centers	Planned U.S. East Coast locations
AHG Planned Research Centers	2 vaccine research centers	Planned U.S. locations
U.S. Radiotherapy Market Size	$2.38 billion	Estimated U.S. market value for 2025

Users seeking health information and AI-driven medical consultation

AHG provides services that touch on health treatment and consultancy support, leveraging technology.

• The company provides health treatment and consultancy support services.
• Recent activity involved utilizing DeepSeek to advance AI in healthcare.

Hospitals and clinics (potential B2B for medical devices)

This segment is critical as the company generates the majority of its revenues from the sale of medical devices business.

Customer Segment Role	Associated Data Point	Context/Relevance
Medical Device Sales (B2B Focus)	Majority of AHG revenue	Indicates primary revenue driver is B2B/device sales
Medical Devices Sold	Defibrillators and anesthesia laryngoscopes	Examples of products sold to healthcare entities
Hospitals & Clinics (Market Share)	More than 51% of revenue share	Share of the overall Radiation Oncology Market in 2024

The company's Earnings Per Share (EPS) for the trailing 12 months was -$0.48, with a Return on Equity (ROE) of -80.26%.

Akso Health Group (AHG) - Canvas Business Model: Cost Structure

You're looking at the cost side of Akso Health Group (AHG) as of late 2025, and honestly, the numbers tell a story of aggressive investment outpacing revenue capture right now. The primary driver of the financial picture is the bottom line: a -$135.0M net loss for the fiscal year ending March 31, 2025. That loss is the result of high operational costs necessary to fuel the growth trajectory we see in revenue.

The core expenses tied directly to sales are significant. The Cost of Goods Sold (COGS), represented by the Cost of Revenue for the period, was $15.06M in FY 2025. This cost base is what supports the medical distribution and e-commerce segments that generated the group's $14.78M in operating revenue for the same year.

General overhead, which includes a portion of marketing and user acquisition efforts, falls under Selling, General & Administrative expenses. For FY 2025, this line item was reported at $3.64M. While the specific breakdown for marketing, promotion, and user acquisition isn't itemized separately in the latest reports, this SG&A figure captures those overheads. To be fair, the aggressive revenue growth of 512.08% suggests substantial spending was necessary to acquire those new customers.

The strategic push into new areas like U.S. oncology centers and internal technology development represents future-facing costs that are likely embedded within the overall loss but lack specific, itemized disclosure for FY 2025 in the available data. We know the company is actively pursuing technological advancement; for instance, Akso Health Group announced the integration of DeepSeek to advance AI in healthcare in February 2025. This kind of development and licensing activity, while critical for the long-term value proposition, requires capital that contributes to the current cost structure, even if the exact dollar amount for Technology and AI development/licensing costs isn't broken out from the general operating expenses.

Here's a quick look at the key cost components we can quantify for the fiscal year ending March 31, 2025 (all figures in millions USD):

Cost Category	FY 2025 Amount (Millions USD)
Net Loss (Overall Result)	-135.0
Cost of Revenue (COGS Proxy)	15.06
Selling, General & Administrative (SG&A)	3.64

The planned Capital expenditure for U.S. oncology centers and research facilities is a major strategic outlay, but the specific dollar amount allocated for this in FY 2025 is not publicly itemized in the financial statements found. The industry context suggests these centers require substantial capital investment for new technology and facilities. Similarly, specific Research and Development Costs, which would encompass AI/DeepSeek licensing and development, are not explicitly detailed for FY 2025, though they are a known strategic focus.

• High operational costs leading to the -$135.0M net loss.
• Cost of Revenue at $15.06M.
• SG&A expenses totaling $3.64M.
• Confirmed strategic investment in AI/DeepSeek technology integration.
• U.S. expansion CAPEX is a planned cost driver, though the amount is undisclosed.

Finance: draft 13-week cash view by Friday.

Akso Health Group (AHG) - Canvas Business Model: Revenue Streams

You're looking at the top-line drivers for Akso Health Group (AHG) as of late 2025. The story here is explosive top-line growth, even if profitability remains a challenge. The total annual revenue for Fiscal Year (FY) 2025, which ended March 31, 2025, hit $14.78M. That represents a massive year-over-year growth rate of 512.08%.

The revenue streams are diversified across three main areas, though one clearly dominates the current financial picture.

Sales of medical devices (currently the majority of revenue)

This segment is the bedrock of Akso Health Group's current income. The company generates the majority of its revenues from the sale of medical devices business. This suggests that the strategic focus, despite the e-commerce platform's visibility, is heavily weighted toward the higher-value, potentially more stable medical hardware side of the operation.

Sales of general consumer goods via the e-commerce platform

The social e-commerce platform, the Xiaobai Maimai App, is the primary vehicle for selling general consumer goods. This platform offers a broad selection, including food, beverages, and cosmetics, alongside the medical devices. This channel is key for market reach and volume, even if the margin profile differs from direct medical device sales.

Revenue from health treatment and consultancy services (emerging)

This is the area to watch for future diversification. Akso Health Group's offerings also extend to health treatment services. While currently described as emerging, this stream represents a move up the value chain from pure product sales into service delivery within the healthcare sector.

Here's a quick look at the key financial metrics tied to this revenue generation as of the latest reporting period:

Revenue Stream Component	FY 2025 Annual Revenue (TTM Mar '25)	FY 2024 Annual Revenue	Revenue Growth (YoY FY25)	Revenue Per Employee (FY25)
Total Operating Revenue	$14.78M	$2.41M	512.09%	$547,326
Medical Devices (Majority Contributor)	Undisclosed Proportion	Undisclosed Proportion	Implied High Growth	Undisclosed Proportion
E-commerce Consumer Goods	Undisclosed Proportion	Undisclosed Proportion	Implied High Growth	Undisclosed Proportion
Health Treatment/Consultancy Services	Undisclosed Proportion (Emerging)	Undisclosed Proportion	Implied High Growth	Undisclosed Proportion

The operational scale supporting this revenue includes a reported employee count of 27 individuals. The company also reported a positive free cash flow of $46.67 million or $1.0M over the trailing twelve months ending March 2025, which is a critical buffer given the negative earnings figures.

You should note the following key characteristics impacting the revenue streams:

• The company operates a social e-commerce platform, the Xiaobai Maimai App.
• The stock has a Price-to-Sales (P/S) Ratio of 29.71 or 29.86.
• The Enterprise Value to Sales (EV/Sales) ratio is 46.02.
• The company has net cash of $174.2M as of March 2025.

Finance: draft 13-week cash view by Friday.